Abstract
By enabling greater signal linearity and multiplexed detection, fluorescent western immunodetection overcomes many of the inherent technical limitations associated with the traditional chemiluminescent detection method. However, the sensitivity of fluorescence detection can be severely compromised by high background autofluorescence of various blotting membranes. Here, we describe a low autofluorescence PVDF membrane (Immobilon®-FL membrane) optimized for fluorescent immunodetection, and we report its use in the quantitative fluorescent western immunodetection of biomarkers associated with Alzheimer’s disease (AD). First, membrane autofluorescence of four different commercially available blotting membranes was compared. Immobilon®-FL membrane exhibited the lowest autofluorescence with substantially increased detection sensitivity. We also show that the fluorescent immunodetection exhibited greatly increased linear dynamic range (two orders of magnitude, log scale) compared to the traditional chemiluminescent methods (less than one order of magnitude). Immobilon®-FL membrane was then used to quantify the expression levels of previously reported biomarkers associated with AD (synaptophysin, GSK3β, and GAP43). Total protein extracts from age-matched brain samples of three AD patients and three normal controls were used. Biomarker expression levels were normalized to that of a housekeeping protein (GAPDH) using multiplexed detection, conserving difficult-to-obtain biological tissue samples and minimizing experimental variation. We found that the expression of GSK3ß and GAP43 biomarkers were significantly reduced in AD brain samples compared to age-matched normal samples. In summary, combining fluorescent immunodetection with a low autofluorescent blotting membrane yields accurate and reliable multiplexed quantitation of AD biomarkers. While this report focuses on the quantitation of AD biomarkers, the described technique is applicable to comparing protein expression in other biological contexts as well.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354
Burnette WN (1981) “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate–polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195–203
Pluskal M, Przekop M, Kavonian M (1986) Immobilon® PVDF transfer membrane: a new membrane substrate for Western blotting of proteins. Biotechniques 4:272–283
Hauber R, Miska W, Schleinkofer L, Geiger R (1989) New, sensitive, radioactive-free bioluminescence-enhanced detection system in protein blotting and nucleic acid hybridization. J Biolumin Chemilumin 4:367–372
Ornberg R, Harper T, Liu H (2005) Western blot analysis with quantum dot fluorescence technology: a sensitive and quantitative method for multiplexed proteomics. Nat Methods 2:79–81
Liao G, Tao Q, Kofron M, Chen J, Schloemer A, Davis R, Hsieh J, Wylie C, Heasman J, Kuan C (2006) Jun NH2-terminal kinase (JNK) prevents nuclear-catenin accumulation and regulates axis formation in Xenopus embryos. Proc Natl Acad Sci U S A 103:16313–16318
Prickett TD, Brautigan DL (2007) Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3. Mol Cell Biol 27:4217–4227
Delaive E, Arnould T, Raes M, Renard P (2008) A sensitive three-step protocol for fluorescence-based Western blot detection. J Immunol Methods 334:51–58
Gingrich J, Davies D, Nguyen Q (2000) Multiplex detection and quantitation of proteins on Western blots using fluorescent probes. Biotechniques 29:636–642
Fradelizi J, Friederich E, Beckerle MC, Golsteyn RM (1999) Quantitative measurement of proteins by western blotting with Cy5-coupled secondary antibodies. Biotechniques 26:484–486
Multiplex protein detection using the ECL Plex fluorescent Western blotting system. GE Healthcare, application note 28-4015-40 AA. http://www.amershambiosciences.com/
Amy S-G, Yonghong Z, Todd H, Dayle M, Michael O (2004) Quantitative, two-color western blot detection with infrared fluorescence. LI-COR Biosciences Application note. www.licor.com
Mount C, Downton C (2006) Alzheimer disease: progress or profit? Nat Med 12:780–784
Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368:387–403
Baum L, Hansen L, Masliah E, Saitoh T (1996) Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol Chem Neuropathol 29:253–261
Bogdanovic N, Davidsson P, Volkmann I, Winblad B, Blennow K (2000) Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer’s disease: an immunohistochemical and quantitative study. Neural Transm 107:463–478
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Park, J., Mabuchi, M., Sharma, A. (2015). Multiplexed Fluorescent Immunodetection Using Low Autofluorescence Immobilon®-FL Membrane. In: Kurien, B., Scofield, R. (eds) Detection of Blotted Proteins. Methods in Molecular Biology, vol 1314. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2718-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2718-0_22
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2717-3
Online ISBN: 978-1-4939-2718-0
eBook Packages: Springer Protocols